EXHIBIT
31.1





CERTIFICATION
OF CHIEF EXECUTIVE OFFICER PURSUANT TO


SECTION
302(a) OF THE SARBANES-OXLEY ACT OF 2002




I,
Qingtai Liu, certify that:





1. I have reviewed this quarterly report
on Form 10-Q of Shengtai Pharmaceutical, Inc.





2. Based on my knowledge, this quarterly
report does not contain any untrue statement of a material fact or omit to state
a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this quarterly report;





3. Based on my knowledge, the financial
statements, and other financial information included in this quarterly report,
fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods
presented in this quarterly report;





4. The registrant’s other certifying
officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:




a) designed such disclosure controls and
procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
quarterly report is being prepared; and




b) designed such internal controls over
financial reporting, or caused such internal controls over financial reporting
to be designed under our supervision, to provide reasonable assurances regarding
the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted
accounting principles; and




c) evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation;
and




d) disclosed in this report any
change in the registrant’s internal controls over financial reporting that
occurred during the registrant’s fiscal quarter ended September 30, 2009, that
has materially affected or is reasonably likely to materially affect the
registrant’s internal controls over financial reporting.





5. The registrant’s other certifying
officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit
committee of registrant’s board of directors (or persons performing the
equivalent functions):




a)all significant
deficiencies and material weakness in the design or operation of internal
controls over financial reporting which are reasonably likely to adversely
affect the registrant’s ability to record, process, summarize and report
financial data; and




b)any fraud, whether or not
material, that involves management or other employees who have a significant
role in the registrant’s internal control over financial reporting.


Date:
      November 15, 2009
              
              /s/
      Qingtai LiuQingtai
      LiuTitle:
      Chief Executive Officer